SHC Sotera Health Company Common Stock
XNAS
17.77
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $13.09 – $19.85
- YTD
- +0.45%
- IV Rank (30D)
- 16.33
- Straddle Price
- $1.93
- P/C Vol Ratio
- 0.02
- Market Cap
- $5.1B
- Open
- $17.93
- Day Range
- $17.75 – $18.16
- Volume
- 2,716,460
- Prev Close
- $17.93
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.38 |
| Cost of Equity (CAPM) | 12.75% (VRP-adj) |
| WACC | 10.50% |
| Volatility Risk Premium | +118.7pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -4.9% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 24.6% |
| Book / Price | 12.2% |
| Gross Margin (TTM) | 55.3% |
| FCF Margin (TTM) | 9.5% |
| Debt / Equity | 3.56 |
| Quality Score | 3/6 — normal (10y DCF) |
| SMA 50 | $18.59 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $18.13 |
| Bollinger Width / SMA20 | 34.2% (drives anchor stability) |
| Net Debt | $1.9B |
| Market Cap | $5B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $-3.32 | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $15.18 | 35% | median 37.0× · 4 peers |
| Peer EV/EBITDA | $30.87 | 35% | median 18.8× · 6 peers |
| Peer P/B | $15.27 | 7% | median 7.0× · 6 peers |
| Peer P/S | $18.19 | 23% | median 4.4× · 6 peers |
| Market Anchor (SMA50) | $18.59 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $17.58 | 0% | 8 strikes · skew +0.44 |

- Industry (SIC)
- SERVICES-MISC HEALTH & ALLIED SERVICES, NEC (8090) · industry map
- Exchange
- XNAS
- Market Cap
- $5.1B
- Employees
- 3,000
- List Date
- 2020-11-20
- CIK
- 0001822479
- Next Earnings
- 2026-11-03 (After-Close)
- EPS Forecast
- $0.24 (3 est.)
- Headquarters
- Broadview Heights, OH
- Homepage
- https://www.soterahealth.com
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. …
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -3.44% | -7.56% | 106.96% | -12.12% | 0.66% | 2.43% | 14.49% |
| Feb | -1.40% | 1.86% | -8.60% | -2.02% | -9.04% | -11.20% | -5.07% |
| Mar | -9.57% | 1.36% | 4.86% | -17.51% | -0.17% | -9.87% | -5.15% |
| Apr | 2.92% | -6.94% | -3.90% | -4.27% | 3.32% | 4.64% | -0.71% |
| May | -4.78% | 3.65% | -14.14% | -0.80% | 1.16% | 0.90% | -2.34% |
| Jun | -0.29% | -7.42% | 32.77% | 3.58% | -8.78% | 14.22% | 5.68% |
| Jul | -2.63% | -2.29% | 3.94% | 19.78% | 0.35% | 0.31% | 3.24% |
| Aug | 4.84% | -11.37% | -14.33% | 13.28% | 46.82% | 5.06% | 7.38% |
| Sep | 4.89% | -60.09% | -6.37% | 8.72% | -2.66% | -1.02% | -9.42% |
| Oct | -5.98% | -6.65% | -13.76% | -3.69% | 2.53% | -1.93%* | -4.91% |
| Nov | -16.15% | 20.87% | 6.06% | -16.96% | 5.24% | -- | -0.19% |
| Dec | 13.60% | -5.23% | 20.36% | 3.25% | 1.67% | -- | 6.73% |
| Total | -19.32% | -68.50% | 99.45% | -14.89% | 37.11% | 1.14% | 5.83% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a range-bound market with potential for breakout or breakdown
- Recent news headlines highlight institutional interest, but overall sentiment is neutral
- Risk metrics indicate above-average volatility, but alpha suggests some outperformance
Primary Risks:
- Volatility regime may lead to significant price moves
- News and technical signals may diverge, impacting stock performance
Investment Thesis: SHC appears to be in a consolidation phase, with recent news highlighting institutional interest. The options market is pricing in a $2.40 move by expiration, which could impact the stock's direction.
Recent News Sentiment Impact: Recent headlines have been generally positive, but the overall sentiment remains neutral. This could indicate that the market is expecting some volatility or uncertainty ahead.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Range-bound with potential for breakout or breakdown
- Medium-term (1-3 months): Consolidation phase
- Long-term (3-12 months): Uptrend
Support/Resistance Levels:
- Upper Bollinger Band: $19.76
- Lower Bollinger Band: $18.15
- 50-day SMA: $18.50
- 20-day EMA: $18.95
Momentum Signals:
- RSI (14): 49.78 (neutral)
- MACD: Bullish crossover above signal line (0.07 / -0.03 / 0.10)
Volume Analysis:
- Volume SMA 20: 2069357.35
- On-Balance Volume (OBV): -11806209.86 (bearish divergence)
- Volume Rate of Change: 153.56% (increasing volume indicates potential breakout or breakdown)
News & Sentiment Analysis
Recent Headlines Summary:
- Recent news highlights institutional interest and potential opportunity amid a 21% stock drop
Sentiment Assessment: Aggregate sentiment is neutral, with some positive headlines and no significant negative news.
Catalyst Identification:
- Upcoming earnings release may impact the stock's direction
Market Narrative:
- News signals are aligned with technical indicators, suggesting a range-bound market with potential for breakout or breakdown
Risk & Volatility Assessment
Risk Metrics:
- Beta: 1.02 (above average volatility)
- Alpha: 0.05 (some outperformance relative to market)
Volatility Regime:
- Historical volatility: HV20 23.1%, HV30 21.7%, HV60 26.8% (above average volatility)
- IV Premium vs HV30: 786.7% (implied richer than realized, suggesting potential for increased volatility)
Options Market Signals:
- IV Rank: 62.8% (Medium - shows if volatility is historically high/low)
- Current IV: 192.8% (highly volatile)
- Expected Move: $2.40 by expiration (28 DTE), 7-DTE: $1.85
Downside Protection:
- Support levels: Lower Bollinger Band, 50-day SMA
- Risk management considerations: Stop-loss levels and position sizing considerations based on market volatility and news sentiment
Market Context & Positioning
Sector Performance:
- Sector relative strength vs. market: Neutral (SHC's performance is aligned with the sector)
Institutional Activity:
- Volume patterns suggest institutional interest and potential buying pressure
Correlation Analysis:
- Correlation coefficient: 0.45 (SHC moves relatively in line with the market, but with some amplification)
Relative Valuation:
- Position within trading range: SHC appears to be in a consolidation phase, with recent news highlighting institutional interest
Key Levels & Action Items
Critical Price Levels:
- Upper Bollinger Band: $19.76 (resistance)
- Lower Bollinger Band: $18.15 (support)
Breakout/Breakdown Levels:
- Potential for breakout or breakdown above/below the upper/lower Bollinger Bands
Time-Sensitive Catalysts:
- Upcoming earnings release may impact the stock's direction
Risk Management:
- Stop-loss levels and position sizing considerations based on market volatility and news sentiment
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-12 | After-Close | 2.44% | 0.81% | 0.33x | Within |
| 2021-11-10 | After-Close | 7.05% | 5.68% | 0.81x | Within |
| 2022-11-02 | After-Close | 27.62% | 2.06% | 0.07x | Within |
| 2023-02-28 | After-Close | 12.28% | 2.34% | 0.19x | Within |
| 2023-05-03 | After-Close | 9.26% | 2.53% | 0.27x | Within |
| 2023-08-03 | After-Close | 7.22% | 1.25% | 0.17x | Within |
| 2023-11-01 | After-Close | 8.94% | 0.47% | 0.05x | Within |
| 2024-01-09 | After-Close | 7.80% | 5.30% | 0.68x | Within |
| 2024-02-27 | After-Close | 8.07% | 13.75% | 1.70x | Exceeded |
| 2024-05-02 | After-Close | 14.67% | 1.01% | 0.07x | Within |
| 2024-08-05 | After-Close | 19.34% | 3.38% | 0.17x | Within |
| 2024-11-05 | After-Close | 26.91% | 4.47% | 0.17x | Within |
| 2025-02-27 | After-Close | 15.07% | 1.55% | 0.10x | Within |
| 2025-05-01 | Pre-Market | 15.22% | 5.22% | 0.34x | Within |
| 2025-08-08 | After-Close | 11.27% | 0.64% | 0.06x | Within |
| 2025-11-04 | Pre-Market | 10.69% | 1.08% | 0.10x | Within |
| 2026-02-24 | After-Close | 13.76% | 3.35% | 0.24x | Within |
| 2026-05-05 | Pre-Market | 12.67% | 0.39% | 0.03x | Within |
| 2026-08-06 | After-Close | 10.44% | 0.26% | 0.02x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
SHC Options Activity & IV Rank
SHC IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 90th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Moderate volatility - stock generally follows market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $35.6M | #849 of 6285 | +190.0% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $34.3M | #814 of 3716 | +506.2% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $342K | #962 of 997 | -97.2% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $7K | #4126 of 4729 | -34.9% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
SHC Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
SHC Insider Trading (Form 4)
Latest: 2026-08-19| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Michael B. Petras Jr. | Executive Chairman | Sell (S) | −1,144,515 | $18.50 | -$21.17M | EDGAR |
| 2026-08-11 | Michael P Rutz | President of Sterigenics | Sell (S) | −150,000 | $18.84 | -$2.83M | EDGAR |
| 2026-08-07 | Jonathan M. Lyons | Sr. Vice President, CFO | Tax (F) | −11,316 | $17.98 | -$203.5K | EDGAR |
| 2026-08-07 | Jonathan M. Lyons | Sr. Vice President, CFO | Tax (F) | −11,316 | $17.98 | -$203.5K | EDGAR |
| 2026-05-27 | David E. Wheadon | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Christopher Simon | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Ruoxi Chen | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Vincent K Petrella | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | James Neary | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Karen Flynn | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Sean Laurence Cunningham | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Kenneth D. Krause | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Richard G Kyle | Director | Award (A) | +14,970 | — | EDGAR | |
| 2026-05-27 | Alton Shader | Chief Executive Officer | Award (A) | +579,573 | — | EDGAR | |
| 2026-05-27 | Ann R. Klee | Director | Award (A) | +14,970 | — | EDGAR |
SHC Insider Holdings
22 insiders · @ $17.77| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Warburg Pincus XI-C, LLC | Director | 34,102,952 | $606.01M | -$4.97B | 3 | 2025-12-05 |
| 2 | GTCR FUND XI/C LP | Director | 29,215,301 | $519.16M | -$939.06M | 1 | 2025-11-12 |
| 3 | Warburg Pincus Partners GP LLC | Director | 19,102,952 | $339.46M | -$3.10B | 2 | 2026-03-10 |
| 4 | Warburg Pincus XI, L.P. | Director | 19,102,952 | $339.46M | -$6.36B | 3 | 2026-03-10 |
| 5 | GTCR CO-INVEST XI LP | Director | 12,735,301 | $226.31M | -$2.16B | 3 | 2026-03-10 |
| 6 | Michael B. Petras Jr. | Executive Chairman | 4,367,305 | $77.61M | -$69.23M | 16 | 2026-08-19 |
| 7 | Alton Shader | Chief Executive Officer | 375,939 | $6.68M | $0 | 1 | 2026-05-27 |
| 8 | Michael P Rutz | President of Sterigenics | 334,279 | $5.94M | -$7.77M | 14 | 2026-08-11 |
| 9 | Alexander Dimitrief | Former SVP, GC and Sec. | 312,040 | $5.54M | $0 | 5 | 2026-04-02 |
| 10 | Jonathan M. Lyons | Sr. Vice President, CFO | 217,304 | $3.86M | $0 | 8 | 2026-08-07 |
SHC Board & Officers
As of SEC filings through Aug 19, 2026Directors 13
- Ann R. Klee · since Nov 20, 2020
- Constantine S Mihas · since Nov 20, 2020
- James Neary · since Nov 20, 2020
- Ruoxi Chen · since Nov 20, 2020
- Sean Laurence Cunningham · since Nov 20, 2020
- Vincent K Petrella · since Nov 20, 2020
- David E. Wheadon · since May 27, 2021
- Robert Brown Knauss · since Oct 12, 2022
- Karen Flynn · since Nov 13, 2023
- Christopher Simon · since Aug 1, 2024
- Michael B. Petras Jr. · listed since Mar 2025
- Kenneth D. Krause · since Mar 16, 2026
- Alton Shader · since May 26, 2026
Officers 5
- Michael B. Petras Jr. · Chairman & CEO · since Nov 20, 2020
- Alton Shader · Chief Executive Officer · since May 26, 2026
- Michael P Rutz · President of Sterigenics · since Nov 20, 2020
- Jonathan M. Lyons · Sr. Vice President, CFO · since Jun 26, 2023
- Erika Ostrowski · SVP, General Counsel and Sec. · since Apr 1, 2026
Changes in the last 10 years (124)
| May 26, 2026 | Alton Shader became a director |
| May 26, 2026 | Alton Shader became Chief Executive Officer |
| May 15, 2026 | Warburg Pincus XI-C, LLC reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus XI-C, LLC reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus XI, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus XI, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus XI Partners, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus XI Partners, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Private Equity XI-C, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Private Equity XI-C, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Private Equity XI-B, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Private Equity XI-B, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Private Equity XI, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Private Equity XI, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Partners II, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Partners II, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Partners II (Cayman), L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Partners II (Cayman), L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus Partners GP LLC reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus Partners GP LLC reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus LLC reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus LLC reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus (Cayman) XI, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus (Cayman) XI, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Warburg Pincus (Bermuda) Private Equity GP Ltd. reported in an SEC filing no longer being a director |
| May 15, 2026 | Warburg Pincus (Bermuda) Private Equity GP Ltd. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | WP XI Partners, L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | WP XI Partners, L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | WP Global LLC reported in an SEC filing no longer being a director |
| May 15, 2026 | WP Global LLC reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | WARBURG PINCUS & CO. reported in an SEC filing no longer being a director |
| May 15, 2026 | WARBURG PINCUS & CO. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Gtcr Partners Xi/a&c LP reported in an SEC filing no longer being a director |
| May 15, 2026 | Gtcr Partners Xi/a&c LP reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Gtcr Investment Xi LLC reported in an SEC filing no longer being a director |
| May 15, 2026 | Gtcr Investment Xi LLC reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Gtcr Fund Xi/c LP reported in an SEC filing no longer being a director |
| May 15, 2026 | Gtcr Fund Xi/c LP reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Gtcr Fund Xi/a LP reported in an SEC filing no longer being a director |
| May 15, 2026 | Gtcr Fund Xi/a LP reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Gtcr Co-Invest Xi LP reported in an SEC filing no longer being a director |
| May 15, 2026 | Gtcr Co-Invest Xi LP reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Bull Holdco L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Bull Holdco L.P. reported in an SEC filing no longer being a 10% owner |
| May 15, 2026 | Bull Co-Invest L.P. reported in an SEC filing no longer being a director |
| May 15, 2026 | Bull Co-Invest L.P. reported in an SEC filing no longer being a 10% owner |
| Apr 2, 2026 | Alexander Dimitrief reported in an SEC filing no longer being SVP, General Counsel and Sec. |
| Apr 1, 2026 | Erika Ostrowski became SVP, General Counsel and Sec. |
| Mar 16, 2026 | Kenneth D. Krause became a director |
| Mar 10, 2026 | Warburg Pincus Partners II, L.P. first listed as a 10% owner in an SEC filing |
| Feb 13, 2026 | Richard G Kyle reported in an SEC filing no longer being a director |
| Feb 4, 2026 | Richard G Kyle became a director |
| Mar 4, 2025 | Michael B. Petras Jr. first listed as a director in an SEC filing |
| Sep 9, 2024 | Warburg Pincus Partners II, L.P. no longer listed as a 10% owner in SEC filings |
| Sep 6, 2024 | The company announced the departure of David Donnini from the board in an SEC filing |
| Aug 1, 2024 | Christopher Simon became a director |
| Mar 6, 2024 | Bull Holdco L.P. first on file as a director |
| Mar 6, 2024 | Bull Holdco L.P. first on file as a 10% owner |
| Mar 5, 2024 | Michael B. Petras Jr. no longer listed as a director in SEC filings |
| Nov 13, 2023 | Karen Flynn became a director |
| Jun 26, 2023 | Jonathan M. Lyons became Sr. Vice President, CFO |
| Nov 1, 2022 | Alexander Dimitrief became SVP, General Counsel and Sec. |
| Oct 12, 2022 | Robert Brown Knauss became a director |
| Oct 7, 2022 | The company announced the departure of Stephanie Geveda from the board in an SEC filing |
| Aug 31, 2022 | The company announced the departure of Terry Hammons as SVP, GC and Secretary in an SEC filing |
| Jul 20, 2022 | Michael F Biehl became Interim CFO |
| May 16, 2022 | The company announced the departure of Scott J. Leffler as CFO and Treasurer in an SEC filing |
| Nov 1, 2021 | Terry Hammons became SVP, GC and Secretary |
| May 27, 2021 | David E. Wheadon became a director |
| Mar 24, 2021 | WP XI Partners, L.P. first on file as a director |
| Mar 24, 2021 | WP XI Partners, L.P. first on file as a 10% owner |
| Nov 20, 2020 | Warburg Pincus XI-C, LLC became a director |
| Nov 20, 2020 | Warburg Pincus XI-C, LLC became a 10% owner |
| Nov 20, 2020 | Warburg Pincus XI, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus XI, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus XI Partners, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus XI Partners, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Private Equity XI-C, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus Private Equity XI-C, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Private Equity XI-B, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus Private Equity XI-B, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Private Equity XI, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus Private Equity XI, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Partners II, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus Partners II, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Partners II (Cayman), L.P. became a director |
| Nov 20, 2020 | Warburg Pincus Partners II (Cayman), L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus Partners GP LLC became a director |
| Nov 20, 2020 | Warburg Pincus Partners GP LLC became a 10% owner |
| Nov 20, 2020 | Warburg Pincus LLC became a director |
| Nov 20, 2020 | Warburg Pincus LLC became a 10% owner |
| Nov 20, 2020 | Warburg Pincus (Cayman) XI, L.P. became a director |
| Nov 20, 2020 | Warburg Pincus (Cayman) XI, L.P. became a 10% owner |
| Nov 20, 2020 | Warburg Pincus (Bermuda) Private Equity GP Ltd. became a director |
| Nov 20, 2020 | Warburg Pincus (Bermuda) Private Equity GP Ltd. became a 10% owner |
| Nov 20, 2020 | WP Global LLC became a director |
| Nov 20, 2020 | WP Global LLC became a 10% owner |
| Nov 20, 2020 | WARBURG PINCUS & CO. became a director |
| Nov 20, 2020 | WARBURG PINCUS & CO. became a 10% owner |
| Nov 20, 2020 | Vincent K Petrella became a director |
| Nov 20, 2020 | Stephanie Geveda became a director |
| Nov 20, 2020 | Sean Laurence Cunningham became a director |
| Nov 20, 2020 | Scott J. Leffler became CFO and Treasurer |
| Nov 20, 2020 | Ruoxi Chen became a director |
| Nov 20, 2020 | Michael P Rutz became President of Sterigenics |
| Nov 20, 2020 | Michael B. Petras Jr. became a director |
| Nov 20, 2020 | Michael B. Petras Jr. became Chairman & CEO |
| Nov 20, 2020 | Matthew J Klaben became SVP, GC and Secretary |
| Nov 20, 2020 | James Neary became a director |
| Nov 20, 2020 | Gtcr Partners Xi/a&c LP became a director |
| Nov 20, 2020 | Gtcr Partners Xi/a&c LP became a 10% owner |
| Nov 20, 2020 | Gtcr Investment Xi LLC became a director |
| Nov 20, 2020 | Gtcr Investment Xi LLC became a 10% owner |
| Nov 20, 2020 | Gtcr Fund Xi/c LP became a director |
| Nov 20, 2020 | Gtcr Fund Xi/c LP became a 10% owner |
| Nov 20, 2020 | Gtcr Fund Xi/a LP became a director |
| Nov 20, 2020 | Gtcr Fund Xi/a LP became a 10% owner |
| Nov 20, 2020 | Gtcr Co-Invest Xi LP became a director |
| Nov 20, 2020 | Gtcr Co-Invest Xi LP became a 10% owner |
| Nov 20, 2020 | David Donnini became a director |
| Nov 20, 2020 | Constantine S Mihas became a director |
| Nov 20, 2020 | Bull Co-Invest L.P. became a director |
| Nov 20, 2020 | Bull Co-Invest L.P. became a 10% owner |
| Nov 20, 2020 | Ann R. Klee became a director |
- Prev
- 1
- …
Not reported recently (2)
- Matthew J Klaben · Last reported as SVP, GC and Secretary in an SEC filing dated Oct 7, 2022
- Michael F Biehl · Last reported as Interim CFO in an SEC filing dated Jul 26, 2022
SHC Proposed Insider Sales (Form 144)
Latest: 2026-08-17What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | Michael B. Petras, Jr. | Chairman, CEO | 1,144,515 | $21.62M | 2026-08-17 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-08-07 | Rutz Michael P | Officer | 150,000 | $2.84M | 2026-08-07 | Charles Schwab Corp. | — | EDGAR |
| 2025-12-08 | Michael B. Petras, Jr. | Chairman, CEO | 750,000 | $12.56M | 2025-12-08 | J.P. Morgan Securities LLC | — | EDGAR |
| 2025-12-04 | GTCR FUND XI/C LP | Owner | 1,295,747 | $21.16M | 2025-12-03 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2025-12-03 | GTCR CO-INVEST XI LP | Owner | 41,219 | $673.1K | 2025-12-03 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2025-12-03 | GTCR FUND XI/A LP | Owner | 5,143,033 | $83.99M | 2025-12-03 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2025-12-03 | WARBURG PINCUS LLC | Affiliate | 9,720,000 | $163.68M | 2025-12-03 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2025-08-22 | Rutz Michael P | Officer | 126,611 | $2.04M | 2025-08-22 | Charles Schwab & Co. | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-22 | 0001822479-26-000034 | EDGAR |
| 2026-05-20 | 0001193125-26-232585 | EDGAR |
| 2026-05-13 | 0001193125-26-221630 | EDGAR |
| 2026-05-05 | 0001822479-26-000028 | EDGAR |
| 2026-03-16 | 0001822479-26-000019 | EDGAR |
| 2026-03-06 | 0001193125-26-096983 | EDGAR |
| 2026-02-24 | 0001822479-26-000012 | EDGAR |
| 2026-02-05 | 0001822479-26-000007 | EDGAR |
| 2026-01-12 | 0001822479-26-000004 | EDGAR |
| 2025-11-10 | 0001193125-25-274199 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-05 | 0001822479-26-000031 | EDGAR |
| 2025-11-04 | 0001822479-25-000054 | EDGAR |
| 2025-08-08 | 0001822479-25-000044 | EDGAR |
| 2025-05-01 | 0001822479-25-000025 | EDGAR |
| 2024-11-05 | 0001822479-24-000049 | EDGAR |
| 2024-08-05 | 0001822479-24-000041 | EDGAR |
| 2024-05-02 | 0001822479-24-000020 | EDGAR |
| 2023-11-01 | 0001822479-23-000063 | EDGAR |
| 2023-08-03 | 0001822479-23-000051 | EDGAR |
| 2023-05-03 | 0001822479-23-000033 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJH iShares Core S&P Mid-Cap ETF | iShares (BlackRock) | 0.15% | $183.3M | $123.0B | 2026-10-20 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $160.2M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.06% | $112.7M | — | 2026-09-30 |
| 4 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.14% | $62.8M | — | 2026-09-30 |
| 5 | VXF Vanguard Extended Market ETF | Vanguard | 0.06% | $59.4M | — | 2026-09-30 |
| 6 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.01% | $40.3M | — | 2026-09-30 |
| 7 | MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust | SPDR (State Street) | 0.15% | $38.3M | $25.8B | 2026-10-20 |
| 8 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.11% | $35.9M | — | 2026-10-20 |
| 9 | IJK iShares S&P Mid-Cap 400 Growth ETF | iShares (BlackRock) | 0.29% | $30.8M | $10.5B | 2026-10-20 |
| 10 | SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF | SPDR (State Street) | 0.15% | $27.6M | $18.4B | 2026-10-20 |
| 11 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.01% | $26.7M | — | 2026-09-30 |
| 12 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.04% | $21.0M | $57.3B | 2026-10-20 |
| 13 | IEFA iShares Core MSCI EAFE ETF | iShares (BlackRock) | 0.01% | $20.7M | $191.0B | 2026-10-20 |
| 14 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.09% | $19.9M | — | 2026-05-31 |
| 15 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.02% | $19.4M | — | 2026-10-20 |
| 16 | VHT Vanguard Health Care ETF | Vanguard | 0.07% | $15.7M | — | 2026-09-30 |
| 17 | MIGO MIG Core ETF | Nport | 2.04% | $15.5M | — | 2026-05-31 |
| 18 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.19% | $14.6M | — | 2026-10-20 |
| 19 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.08% | $11.2M | — | 2026-05-31 |
| 20 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.01% | $11.1M | $84.5B | 2026-10-20 |
| 21 | VSS Vanguard FTSE All-World EX-US Small-Cap Index Fund | Vanguard | 0.07% | $10.2M | — | 2026-09-30 |
| 22 | SCZ iShares MSCI EAFE Small-Cap ETF | iShares (BlackRock) | 0.08% | $9.8M | $12.9B | 2026-10-20 |
| 23 | VNQI Vanguard Global ex-U.S. Real Estate ETF | Vanguard | 0.27% | $9.7M | — | 2026-09-30 |
| 24 | IVOO Vanguard S&P Mid-Cap 400 ETF | Vanguard | 0.15% | $8.8M | — | 2026-09-30 |
| 25 | MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF | SPDR (State Street) | 0.29% | $8.3M | $2.8B | 2026-10-20 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $280.05M | $26.59M | $0.09 | $29.43M |
| Q4 '25 | 2025-12-31 | $303.44M | $34.85M | $0.12 | $103.10M |
| Q3 '25 | 2025-09-30 | $311.31M | $48.40M | $0.17 | $71.15M |
| Q2 '25 | 2025-06-30 | $294.34M | $7.96M | $0.03 | $57.42M |
| Q1 '25 | 2025-03-31 | $254.52M | $-13.26M | $-0.05 | $55.52M |
| Q4 '24 | 2024-12-31 | $290.20M | $12.32M | $0.05 | $55.72M |
| Q3 '24 | 2024-09-30 | $285.47M | $17.00M | $0.06 | $97.45M |
| Q2 '24 | 2024-06-30 | $276.59M | $8.75M | $0.03 | $61.30M |
| Q1 '24 | 2024-03-31 | $248.18M | $6.32M | $0.02 | $9.70M |
| Q4 '23 | 2023-12-31 | $310.24M | $38.68M | $0.14 | $113.12M |
| Q3 '23 | 2023-09-30 | $263.18M | $-13.66M | $-0.05 | $41.85M |
| Q2 '23 | 2023-06-30 | $255.28M | $23.51M | $0.08 | $-336.57M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.